Vireo Growth (VREOF) Debt to Equity (2020 - 2026)
Vireo Growth's (VREOF) quarterly Debt to Equity came in at $0.68 in Q1 2026, down 45.53% year-on-year from $1.24 in Q1 2025, and up 44.25% quarter-over-quarter from $0.47 in Q4 2025.
Vireo Growth (VREOF) Debt to Equity (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Debt to Equity across 7 years of filings, most recently posting $0.68 for Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.68, down 45.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.68 (down 45.53% YoY), and the FY2025 annual result was $0.47, down 58.82% from the prior year.
- Debt to Equity came in at $0.68 for Q1 2026 at Vireo Growth, up from $0.47 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $16.86 in Q4 2022 to a low of -$28.15 in Q1 2023.
- The 5-year median for Debt to Equity is $0.47 (2025), against an average of -$1.8.
- Across the five-year window, Debt to Equity jumped 2553.76% in 2022 and tumbled 2723.03% in 2023, its largest moves.
- Vireo Growth's Debt to Equity stood at $16.86 in 2022, then plunged by 144.51% to -$7.51 in 2023, then soared by 115.14% to $1.14 in 2024, then plunged by 58.82% to $0.47 in 2025, then jumped by 44.25% to $0.68 in 2026.
- The last three Debt to Equity figures came in at $0.68 (Q1 2026), $0.47 (Q4 2025), and $0.54 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Vireo Growth | - | - | 59.30 Mn | 0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.54 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 1.24 |
| Dec 31, 2024 | 1.14 |
| Sep 30, 2024 | -5.27 |
| Jun 30, 2024 | -2.78 |
| Mar 31, 2024 | -2.70 |
| Dec 31, 2023 | -7.51 |
| Sep 30, 2023 | -4.63 |
| Jun 30, 2023 | -7.29 |
| Mar 31, 2023 | -28.15 |
| Dec 31, 2022 | 16.86 |
| Sep 30, 2022 | 3.38 |
| Jun 30, 2022 | 1.91 |
| Mar 31, 2022 | 1.07 |
| Dec 31, 2021 | 0.64 |
| Sep 30, 2021 | 0.38 |
| Jun 30, 2021 | 0.33 |